Skip to main content
. 2021 Apr 26;22(9):4537. doi: 10.3390/ijms22094537

Figure 1.

Figure 1

Docking modeling FTO binding sites of the inhibitors: (a) compound 2, 4-amino-8-chloroquinoline-3-carboxylic acid and (b) compound 3, 8-aminoquinoline-3-carboxylic acid.